Tookitaki, AI Compliance Solution Drives Expansion Across Key Asian Markets with Funding from True Global Ventures

2024-10-21 True Global Ventures HaiPress

Strategic funding to accelerate Tookitaki's growth and drive innovation in financial crime prevention across Asia.

SINGAPORE,Oct. 21,2024 -- True Global Ventures (TGV) Opportunity Fund,a global venture capital firm specializing in transformative technologies,has made a strategic investment inTookitaki,a leader in anti-financial crime software. This capital will fuel Tookitaki's rapid expansion and continued innovation across Asia,as financial institutions face mounting regulatory pressures to combat increasingly sophisticated financial crimes.


The capital injection,which comes as Tookitaki reaches its 10-year anniversary,will supportTookitaki's mission to deliver cutting-edge anti-financial crime solutions to financial institutions in these regions,where compliance with anti-money laundering (AML) and fraud prevention regulations is becoming increasingly critical. Tookitaki has monitored over 10 billion transactions across 100 million consumers amongst its clients. The capital will be key to expandingTookitaki's footprint in key Asian markets,supporting its mission to deliver cutting-edge financial crime solutions to banks and fintech companies in the region.

Beatrice Lion,General Partner of True Global Ventures,stated:


"Our investment inTookitakireflects our confidence in their groundbreaking technology and unique ability to tackle financial crime across Asia's key markets. As regulatory standards tighten and financial crime evolves,Tookitaki's platforms provide scalable,AI-driven solutions for AML and fraud prevention that will help institutions stay ahead of these challenges. We are excited to support their journey of growth."

Abhishek Chatterjee,Founder and CEO ofTookitaki,commented:


"We are thrilled to welcome True Global Ventures as we continue our growth trajectory. This partnership comes at a pivotal time forTookitaki,allowing us to expand our reach in key Asian markets and further enhance our FinCense and AFC Ecosystem platforms. TGV's deep expertise in scaling technology businesses globally will be invaluable as we continue to empower financial institutions with the tools they need to effectively combat financial crime. We're excited for the next phase of this journey."

Tookitaki: Revolutionizing Financial Crime Detection and Prevention in Asia

FinCenseplatform offers a robust,AI-driven solution for AML and fraud prevention,enabling financial institutions to identify and address financial crime with greater accuracy and efficiency. TheAFC Ecosystem,brings together industry experts and institutions to continuously update and refine crime detection models,offering real-time unparalleled collective intelligence.

Both platforms employTookitaki'sfederated learningapproach,allowing institutions to leverage insights from diverse datasets without compromising data privacy,a critical factor in today's heavily regulated financial landscape. This ensures financial institutions can meet compliance standards while benefiting from cutting-edge crime detection technology that adapts to new threats.

https://www.tookitaki.com/

About True Global Ventures:

True Global Ventures is a global venture capital firm with a focus on technology-driven businesses,particularly in AI,blockchain,and other disruptive industries. The TGV Opportunity Fund invests in late-stage technology companies with the potential to drive transformative change. With a strong track record of supporting AI-driven ventures,TGV helps businesses deliver meaningful impact across industries.

www.tgv4plus.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.
©copyright 2009-2020 Health Medical Daily       Contact Us   SiteMap